345.59MMarket Cap-2.19P/E (TTM)
1.315High1.160Low1.70MVolume1.300Open1.320Pre Close2.08MTurnover1.22%Turnover RatioLossP/E (Static)292.87MShares1.93052wk High6.24P/B164.04MFloat Cap0.65152wk Low--Dividend TTM139.02MShs Float69.450Historical High--Div YieldTTM11.74%Amplitude0.651Historical Low1.220Avg Price1Lot Size
Precigen Stock Forum
go go go
Precigen Completes Submission of BLA with Request for Priority Review to the FDA for PRGN-2012 for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Monday, 30th December at 7:00 am
– PRGN-2012 has the potential to be the first FDA-approved therapeutic for the treatment of adults with RRP, a rare and devastating chronic disease for which the current standard-of-care is repeated surgeries –
– PRGN-2012 received Breakthrough Therapy Designation fr...
Precigen Receives Orphan Drug Designation For PRGN-2012 For Treatment Of Recurrent Respiratory Papillomatosis From The European Commission
$Advanced Micro Devices (AMD.US)$ $Aridis Pharmaceuticals (ARDS.US)$ $Alarum Technologies (ALAR.US)$ $180 Life Sciences (ATNF.US)$ $First Wave BioPharma (FWBI.US)$ $IBM Corp (IBM.US)$ $MasterCard (MA.US)$ $Microsoft (MSFT.US)$ $Mullen Automotive (MULN.US)$ $Novo Integrated Sciences (NVOS.US)$ $Ocuphire Pharma (OCUP.US)$ $Precigen (PGEN.US)$ $Tesla (TSLA.US)$ $Minerva Surgical (UTRS.US)$
In reaction to earnings/guidance:
• $Deutsche Bank (DB.US)$ +5.6%, $Salesforce (CRM.US)$ +2.3%, $H.B. Fuller (FUL.US)$ +2.2%, $Trip.com (TCOM.US)$ +0.7%
Other news:
• $Precigen (PGEN.US)$ +3.9% (names new COO)
• $Scorpio Tankers (STNG.US)$ +2.7% (reports it purchased its common shares in the open market and exercised a purchase option for an LR2 product tanker that is currently leased)
• $Marinus Pharmaceuticals (MRNS.US)$ +1.6% (...
No comment yet